retatrutide phase 2 trial new england journal of medicine approval: FDA status, clinical results, and when it could be available Retatrutide Dosing Schedule: Proven 2026

By contrast, countries like India, which do not award patent term extensions, could see generic competition entering much sooner once the patents on the main compound expire there in 2026

Recurring burps with a rotten egg smell, on the other hand, may come from something more serious

AGA rapid clinical practice update on the management of patients taking GLP-1 receptor agonists prior to endoscopy: communication

While the individual pathologies of MASLD and ALD are well-established, the specific pathophysiological mechanisms for MetALD development remain under active investigation and are currently considered hypothetical models that require further clinical validation